42 matches.
- AnnouncementsEBG Advisors Selected to Help Launch NIST’s U.S. AI Safety Institute Consortium3 minute read
- PublicationsWhat GCs Need to Know About Algorithmic Bias3 minute read
- BlogsFDA Oversight of AI Software Developed by Health Care Providers23 minute read
- Media CoverageEpstein Becker Green Forms Collaboration with Data, Social Scientists for AI Consulting5 minute read
- AnnouncementsEBG Advisors and Epstein Becker Green Expand AI Advisory Capabilities Backed by Nearly 1,000 Projects Across Hundreds of Clients5 minute read
- EventsAchieving Legal Compliance in AI: Minimizing Bias in Algorithms3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Ready or Not, AI Chatbots Are Coming to Hospitals”3 minute read
- PublicationsWhy a Data Scientist Needs a Lawyer to Correct Algorithmic Discrimination4 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Draft Guidance Allows AI/ML Devices to Evolve Without Requiring New Submissions”5 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Draft Guidance for AI Change Control Shifts Workload to Initial Premarket Filing”1 minute read
- EventsLegal Framework of AI in the United States1 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Growth of AI in Mental Health Raises Fears of Its Ability to Run Wild”4 minute read
- Media CoverageBradley Merrill Thompson Quoted in “The FDA Plans to Regulate Far More AI Tools as Devices. The Industry Won’t Go Down Without a Fight”2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “NIST Releases New AI Risk Management Framework for ‘Trustworthy’ AI”3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Outlook 2023: The Regulatory Path Ahead”2 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Torres Says Regulatory Alignment a Pressing Consideration for AI Change Control Draft”October 24, 20222 minute read
- Media CoverageBradley Merrill Thompson Quoted in “A ‘Disaster,’ or a ‘Clear Path’ Forward?: New FDA Guidance on AI in Medicine Sparks Strong Reactions”2 minute read
- EventsTech Briefs: Artificial Intelligence and Machine Learning—Making Medical Devices SmarterAugust 25, 20222 minute read
- EventsFDLI: Legal and Regulatory Opportunities to Address Bias and Transparency in Artificial Intelligence/Machine Learning in Medical DevicesJune 14, 20221 minute read
- EventsExplainable Artificial Intelligence and Transparency: Legal Risks and Remedies for the "Black Box" ProblemJune 9, 20222 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Racial Equity Increasing in Device Trials, but Reporting Remains Low”March 29, 20222 minute read
- Media CoverageBradley Merrill Thompson Quoted in “Top Med-Tech Trends of 2021: Regulatory Torpor Adding Drag to Advances in Artificial Intelligence, Machine Learning”6 minute read
- EventsTransparency in AIDecember 9, 20211 minute read
- PublicationsSenior Industry Leaders Need to Learn About AI3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “After the Buzz, AI Finding Its Place in Health Care”2 minute read
- EventsEU-US Webinar: Shaping the Future of Artificial Intelligence (AI) Within Life SciencesSeptember 30, 20212 minute read
- EventsArtificial Intelligence: Bias and Explainability in Algorithms2 minute read
- EventsNIST’s Proposal on Bias in Artificial Intelligence Roundtable3 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Regulation of AI Complicated by Hospital’s Use of In-House Algorithms”4 minute read
- EventsBias in Artificial Intelligence: Legal Risks and Solutions3 minute read
- PublicationsData Quality for AI in Healthcare2 minute read
- BlogsExploring Intentional Bias in the Marketing of Consumer Products4 minute read
- BlogsBias in Healthcare Algorithms5 minute read
- Media CoverageBradley Merrill Thompson Quoted in “FDA Promises a Draft Guidance for Change Control for Artificial Intelligence in 2021”2 minute read
- EventsVirtual Engineering Week: FDA & Medical Artificial Intelligence - What You Need to Know1 minute read
- EventsRAPS Convergence 2020: Software as Medical Device - Has AI Learned Too Much?2 minute read
- PublicationsPostmarket Responsibilities for Medical AI: Part III — FDA Should Not Expand Its Oversight of Commercialized AI3 minute read
- PublicationsPostmarket Responsibilities for Medical AI: Part II — What Industry Should Do in Commercializing Medical AI2 minute read
- PublicationsPost-Market Responsibilities for Medical AI: Part I – FDA's Plan to Increase Its Oversight3 minute read
- EventsFDA Registration for Digital Health – AI2 minute read
- PublicationsFDA's Support of AI in Telemedicine2 minute read
- PublicationsNew Developments in FDA Regulation of AI2 minute read